Zusammenfassung
Die chirurgische Therapie der Schilddrüsenkarzinome hat in den letzten Jahren aufgrund verfeinerter Techniken und Nachsorgekonzepte weltweit erhöhte Aufmerksamkeit gefunden. Wegen der tumorbiologischen Besonderheiten der 5 Haupttypen der Schilddrüsenkarzinome und der hiermit in Verbindung stehenden unterschiedlichen adjuvanten (Radiojodtherapie) bzw. additiven (Radiojodtherapie, externe Strahlentherapie, Chemotherapie) Therapieverfahren steht der primäre Karzinomtyp im Mittelpunkt der chirurgischen Therapiestratifizierung. Abhängig von der Ausdehnung des Primärtumors (extrathyreoidal vs. intrathyreoidal) und vom lokoregionären Lymphknotenbefall kann ein erhebliches lokoregionäres Rezidivrisiko bestehen. Aufgrund der zwar reduzierten, aber trotz Rezidiv auch im Langzeitverlauf nicht ungünstigen Prognose ist bei Fehlen einer progredienten Fernmetastasierung insbesondere bei differenzierten und medullären Karzinomen grundsätzlich die Indikation zur Rezidivresektion gegeben. Die Diagnostik von Primärtumoren und Rezidiven konnte insbesondere durch Sonographie und PET/CT wesentlich verbessert werden und hat dadurch nicht nur zu einer früheren Diagnosestellung, sondern auch zu einem differenzierten Verständnis der Tumorbiologie beigetragen.
Abstract
In recent years surgical therapy of thyroid carcinoma has received increased attention worldwide due to refined techniques and postoperative concepts. Due to the biological characteristics of the five main types of thyroid carcinoma and the corresponding different adjuvant (radioiodine therapy) and additive (radioiodine therapy, external radiation therapy and chemotherapy) therapeutic procedures, the type of primary carcinoma is the focus of surgical therapy stratification. There can be a substantial locoregional risk of recurrence depending on the spread of the primary tumor (extrathyroidal versus intrathyroidal) and the locoregional lymph node infestation. Due to the reduced but despite recurrence not unfavorable prognosis even in the long-term, the indications for resection of recurrences are given by a lack of progressive distant metastization especially for differentiated and medullary carcinomas. The diagnostics of primary tumors and recurrences have been substantially improved especially by sonography and PET-CT and have led not only to an earlier diagnosis but also to a differentiated understanding of tumor biology.
This is a preview of subscription content, access via your institution.



Literatur
Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–384
Brauckhoff M, Meinicke A, Bilkenroth U et al (2006) Long-term results and functional outcome after cervical evisceration in patients with thyroid cancer. Surgery 140:953–955
Brauckhoff M, Dralle H (2009) Zervikoviszerale Resektionen beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 80:88–98
British Thyroid Association (2002) Guidelines for the management of thyroid cancer in adults. Royal College of Physicians
British Thyroid Association (2007) Guidelines for the management of thyroid cancer in adults. Royal College of Physicians. Second edition
Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947–953
Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167
Delbridge L, Barraclough B, Parky R et al (2002) Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg 72:844–845
DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and generetics of tumors of endocrine organs: World health organization classification of tumors. IARC Press, Lyon
Dralle H, Scheumann GFW, Meyer HJ et al (1992) Cervical procedure at the aerodigestive tract in advanced thyroid cancer. Chirurg 63:282–290
Dralle H, Scheumann GFW, Hundeshagen H et al (1992) Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom. Langenbecks Arch Surg 377:34–44
Dralle H, Scheumann GFW, Kotzerke J, Brabant EG (1992) Surgical management of MEN 2. Rec Res Cancer Res 125:167–195
Dralle H, Damm I, Scheumann GFW et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112–121
Dralle H, Gimm O (1996) Lymphadenektomie beim Schilddrüsenkarzinom. Chirurg 67:788–806
Dralle H, Gimm O, Simon D et al (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–751
Dralle H, Brauckhoff M, Machens A, Gimm O (2005) Surgical management of advanced thyroid cancer invading the aerodigestive tract. In: Clark OH, Duh QY, Kebebew E (eds) Textbook on endocrine surgery. 2nd edn. Elsevier Saunders, Philadelphia, p 318–333
Dralle H, Machens A (2008) Surgical approaches in thyroid cancer and lymph-node metastases. Best Pract Res Clin Endocrinol Metab 22:971–987
Dralle H, Machens A, Lorenz K (2008) Hereditäre Schilddrüsenkarzinome. Chirurg 79:1017–1028
Dralle H, Lorenz K, Machens A, Nguyen TP (2009) Postoperativer Zufallsbefund Schilddrüsenkarzinom: chirurgisches Konzept. Dtsch Med Wochenschr 134:2517–2520
Dralle H, Lorenz K, Machens A (2009) Chirurgie der Schilddrüsenkarzinome. Chirurg 80:1069–1083
Dralle H, Machens A (2009) Lymph node dissection in thyroid cancer. In: Hubbard JGH, Inabnet WB, Lo CY (eds) Endocrine Surgery. Springer, London, pp 173–193
Garbe C, Albers P, Beckmann MW et al (2006) Kurzgefaßte interdisziplinäre Leitlinien 2006. Deutsche Krebsgesellschaft e. V. Zuckschwerdt, München, S53–S61
Grillo HC, Suen HC, Mathisen DJ, Wain JC (1992) Resectional management of thyroid carcinoma invading the airway. Ann Thorac Surg 54:3–10
Grünwald F, Kalicke T, Feine U et al (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med Mol Imaging 26:1547–1552
Hartel W, Junginger TH (1996) Leitlinien der Therapie maligner Schiddrüsentumoren. Beilage zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie. Heft 3
Ito Y, Tomoda C, Uruno T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121
Ito Y, Uruno T, Takamura Y et al (2005) Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher agressive characteristics on immuno-histochemical examination.Oncology 68:87–96
Ito Y, Jikuzono T, Higashiyama T et al (2006) Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 30:1821–1828
Ito Y, Tomoda C, Uruno T et al (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30:91–99
Ito Y, Miyauchi A (2007) Lateral and mediastinale lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31:905–915
Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 19:565–612
Kouvaraki MA, Lee JE, Shapiro SE et al (2004) Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136:1189–1191
Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729
Lee YS, Kim SW, Kang HS et al (2007) Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg 31:1954–1959
Machens A, Hinze R, Lautenschläger C et al (2001) Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery 129:23–28
Machens A, Hinze R, Lautenschläger C et al (2001) Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg 136:941–944
Machens A, Lautenschläger C, Thomusch O et al (2001) Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid 11:373–380
Machens A, Hinze R, Thomusch O et al (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22–28
Machens A, Niccoli-Sire P, Hoegel J (2003) Early malignant progression of hereditary medullary thyroid carcinoma. N Engl J Med 349:1517–1525
Machens A, Holzhausen HJ, Lautenschläger C et al (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98:712–719
Machens A, Schneyer U, Holzhausen HJ et al (2005) Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029–2034
Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31:1960–1965
Machens A, Hauptmann S, Dralle H (2008) Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 95:586–591
Machens A, Lorenz K, Dralle H (2009) Individualization of lymph node dissection in RET carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin level. Ann Surg 250:305–310
Machens A, Hauptmann S, Dralle H (2009) Lymph node dissection in the lateral neck for completion in central node-positive papillary thyorid cancer. Surgery 145:176–181
Machens A, Dralle H (2009) Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 16:171–176
Miyauchi A, Matsuzuka F, Hival K et al (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24:1367–1372
Modigliani E, Cohen R, Compos JM et al (1998) Prognostic factors for survival factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol (Oxf) 48:265–273
Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–888
Passler C, Scheuba C, Asari R et al (2005) Importance of tumor size in papillary and follicular thyroid cancer. Br J Surg 92:184–189
Pulcrano M, Boukheris H, Talbot M et al (2007) Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 17:639–646
Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249–256
Raffel A, Cupisti K, Krausch M et al (2004) Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg 28:397–401
Robbins KT, Medina JE, Wolfe GT et al (1991) Standardizing neck dissection terminology. Arch Otolaryngol Head Neck Surg 117:601–605
Robbins KT, Clayman G, Levine PA et al (2002) And the committee for Hand and Neck Surgery and Oncology, American Academy of Otolaryngology-Head and Neck Surgery. Neck dissection classification uptdate. Arch Otolaryngol Head Neck Surg 128:751–758
Robbins RJ, Wan Q, Rewal RK et al (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498–505
Scheumann GFW, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–568
Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393
Scollo C, Baudin E, Travagli JP et al (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075
Shaha A (2001) Invited commentary. Minimally invasive follicular thyroid carcinoma. Surgery 130:119–120
Sobrinho-Simoes M, Noguchi SU, Mazzaferri EL et al (2004) In: DeLellis RA, Lloyd RV, Heitz PU (eds) Tumours of endocrine organs. Pathology and genetics. World Health Organization classification of tumours. IARC Press, Lyon
Sugitani I, Kasai N, Fujimoto Y et al (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139–148
Sywak M, Cornfod L, Roach P et al (2006) Routine ipsilateral level 6 lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1007
Vasko V, Hu S, Wu G et al (200s5) High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph node. J Clin Endocrinol Metab 90:5265–5269
Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas. Ann Surg 237:399–407
White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904
Wittekind CH, Greene FL, Henson DE et al (2003) TNM supplement. 3rd ed. Wiley-Liss, New York. 25–30
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dralle, H., Lorenz, K., Machens, A. et al. Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse. Onkologe 16, 666–677 (2010). https://doi.org/10.1007/s00761-010-1868-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-010-1868-9